Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: ALS

Weizmann Institute-Born Cell Therapy Technology In Clinical Trials for ALS Patients

Kadimastem, an Israeli biopharma venture, recently declared it was hoping to discuss with the U.S. Food and Drug Administration (FDA) […]

Weizmann Institute-Born Cell Therapy Technology In Clinical Trials for ALS Patients
1 year ago
Share

Amylyx Pharmaceuticals & Mass General CENTAUR Trial Evidences Potential for Treating ALS

The AMG Center for ALS at Mass General recently announced, along with Amylyx Pharmaceuticals, Inc., that AMX0035 demonstrated a significant treatment […]

Amylyx Pharmaceuticals & Mass General CENTAUR Trial Evidences Potential for Treating ALS
1 year ago
Share

Apple-Platform-Based APP Launched to Track Amyotrophic Lateral Sclerosis Progression in Clinical Trials

The ALS Never Surrender Foundation, a volunteer-based, non-profit organizations on a mission to cure Motor Neuron Disease and Amyotrophic Lateral […]

Apple Platform-based APP Launched to Track Amyotrophic Lateral Sclerosis Progression in Clinical Trials
1 year ago
Share

University of Arizona Research Team Discovers ALS Diseased Neurons Respond Favorably to Glucose

University of Arizona researchers have identified that increasing glucose, transformed into energy, can potentially give people afflicted with amyotrophic lateral […]

Amyotrophic Lateral Sclerosis
2 years ago
Share

Southern Research Receives Funding for Early-Stage ALS Research

A Southern Research Scientist’s early-stage work on potential new therapies for amyotrophic lateral sclerosis (ALS) is getting a push thanks […]

ALS
2 years ago
Share

Italian Sponsored Phase I Trial Transplants Human Neural Stem Cells into ALS Patients

A recent Phase 1 clinical trial involving the injection of human lateral sclerosis (ALS) was found safe and did not […]

human neural stem cells
2 years ago
Share

Barrow Neurological Center Discover Critical RNA Processing Aberrations

MedicalXpress reports that the Barrow Neurological Center researchers discovered that a specific RNA processing protein, known as ADAR2, undergoes cellular […]

2 years ago
Share

Columbia University & Project ALS $6.3 Million ALS Clinical Research Initiative

Columbia University and Project ALS today announced the Project ALS Therapeutics Core at Columbia, a 3-year, $6.3M initiative toward the first meaningful therapies […]

2 years ago
Share

St. Jude Children’s Research Hospital Breakthrough Could Lead to Future ALS Treatments

WMC 5 News showcases Dr. Mondira Kandu and her research efforts for St. Jude Children’s Research Hospital.  Recently her team […]

2 years ago
Share

Institute for EthnoMedicine Pursues Novel Clues for ALS and Parkinson’s Disease

Institute for EthnoMedicine (the Institute) Brain Chemistry Labs is located in Jackson Hole, Wyoming. Nestled next to the Tetons—a spectacular […]

2 years ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.